Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort

Recent evidence suggests an association of β-amyloid (Aβ) with vascular risk factors and the medications to treat them, which could potentially obfuscate the usefulness of Aβ for prediction of mild cognitive impairment (MCI) or Alzheimer disease (AD). In a subcohort from the Alzheimer’s Disease Anti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abdullah, Laila, Luis, Cheryl, Paris, Daniel, Mouzon, Benoit, Ait-Ghezala, Ghania, Keegan, Andrew P, Wang, Duolao, Crawford, Fiona, Mullan, Michael
Format: Artigo
Idioma:Inglês
Publicat: ScholarOne 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2730348/
https://ncbi.nlm.nih.gov/pubmed/19707525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2009.00083
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars